The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity

NeuroImage: Clinical

Volumn 11, Issue , 2016, Pages 53-60

  Kraehenmann, Rainer ^a   Schmidt, André ^b,c   Friston, Karl ^d   Preller, Katrin H ^a   Seifritz, Erich ^a   Vollenweider, Franz X ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Depression; Dynamic causal modeling; fMRI; Psilocybin; Serotonin

Indexed keywords

PLACEBO; PSILOCYBINE; SEROTONIN AGONIST;

ADULT; AMYGDALA CONNECTIVITY; AMYGDALOID NUCLEUS; ANXIETY DISORDER; ARTICLE; BAYES THEOREM; BRAIN FUNCTION; CAUSAL MODELING; CONNECTOME; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DSM-IV; DYNAMICS; EMOTIONAL BIAS; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HEMODYNAMICS; HUMAN; INFERIOR FRONTAL GYRUS; LATERAL PREFRONTAL CORTEX; LIMBIC SYSTEM; MALE; MOOD DISORDER; NEUROMODULATION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITIVE AND NEGATIVE AFFECT SCHEDULE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATE TRAIT ANXIETY INVENTORY; STRIATE CORTEX; STRUCTURED INTERVIEW; THREAT; TIME SERIES ANALYSIS; AMYGDALA; BRAIN MAPPING; DRUG EFFECTS; FEAR; NERVE TRACT; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; YOUNG ADULT;

ADULT; AMYGDALA; BAYES THEOREM; BRAIN MAPPING; FEAR; FEMALE; HUMANS; MALE; NEURAL PATHWAYS; PREFRONTAL CORTEX; PSILOCYBIN; SEROTONIN RECEPTOR AGONISTS; YOUNG ADULT;

EID: 84970923257     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2015.08.009     Document Type: Article

References (41)

1. Ashburner J., and Friston K.J. Unified segmentation Neuroimage 26 3 2005 839 851 10.1016/j.neuroimage.2005.02.018 15955494
2. 2A serotonin receptor in the modulation of emotion-based actions? Mol. Neurobiol. 48 3 2013 841 853 10.1007/s12035-013-8472-0 23696058
3. Dima D., Stephan K.E., Roiser J.P., Friston K.J., and Frangou S. Effective connectivity during processing of facial affect: evidence for multiple parallel pathways J. Neurosci. 31 40 2011 14378 14385 10.1523/JNEUROSCI.2400-11.2011 21976523
4. Disner S.G., Beevers C.G., Haigh E.A.P., and Beck A.T. Neural mechanisms of the cognitive model of depression Nat. Rev. Neurosci. 12 8 2011 467 477 10.1038/nrn3027 21731066
5. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., and Benjamin L.S. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) 1997 American Psychiatric Press, Inc. Washington, D.C.
6. Fisher P.M., Meltzer C.C., Price J.C., Coleman R.L., Ziolko S.K., Becker C., Moses-Kolko E.L., Berga S.L., and Hariri A.R. Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling Cereb. Cortex 19 11 2009 2499 2507 10.1093/cercor/bhp022 19321655
7. Freese J.L., and Amaral D.G. The organization of projections from the amygdala to visual cortical areas TE and V1 in the macaque monkey J. Comp. Neurol. 486 4 2005 295 317 10.1002/cne.20520 15846786
8. Frick A., Howner K., Fischer H., Kristiansson M., and Furmark T. Altered fusiform connectivity during processing of fearful faces in social anxiety disorder Transl. Psychiatry 3 2013 e312 10.1038/tp.2013.85 24105443
9. Friston K.J., Harrison L., and Penny W. Dynamic causal modelling Neuroimage 19 4 2003 1273 1302 10.1016/S1053-8119(03)00202-7 12948688
10. Friston K.J., Holmes A.P., Worsley K.J., Poline J.-P., Frith C.D., and Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach Hum. Brain Mapp. 2 4 1994 189 210 10.1002/hbm.460020402
11. Furl N., Henson R.N., Friston K.J., and Calder A.J. Top-down control of visual responses to fear by the amygdala J. Neurosci. 33 44 2013 17435 17443 10.1523/JNEUROSCI.2992-13.2013 24174677
12. Goulden N., McKie S., Thomas E.J., Downey D., Juhasz G., Williams S.R., Rowe J.B., Deakin J.F.W., Anderson I.M., and Elliott R. Reversed frontotemporal connectivity during emotional face processing in remitted depression Biol. Psychiatry 72 7 2012 604 611 10.1016/j.biopsych.2012.04.031 22682158
13. Grefkes C., Wang L.E., Eickhoff S.B., and Fink G.R. Noradrenergic modulation of cortical networks engaged in visuomotor processing Cereb. Cortex 20 4 2010 783 797 10.1093/cercor/bhp144 19687293
14. Hahn A., Stein P., Windischberger C., Weissenbacher A., Spindelegger C., Moser E., Kasper S., and Lanzenberger R. Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder Neuroimage 56 3 2011 881 889
15. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., and Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala Science 297 5580 2002 400 403 10.1126/science.1071829 12130784
16. Hasler F., Grimberg U., Benz M.A., Huber T., and Vollenweider F.X. Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study Psychopharmacology (Berl.) 172 2 2004 145 156 10.1007/s00213-003-1640-6 14615876
17. Herrington J.D., Taylor J.M., Grupe D.W., Curby K.M., and Schultz R.T. Bidirectional communication between amygdala and fusiform gyrus during facial recognition Neuroimage 56 4 2011 2348 2355 10.1016/j.neuroimage.2011.03.072 21497657
18. Kastner S., De Weerd P., Desimone R., and Ungerleider L.G. Mechanisms of directed attention in the human extrastriate cortex as revealed by functional MRI Science 282 5386 1998 108 111 10.1126/science.282.5386.108 9756472
19. Kometer M., Schmidt A., Bachmann R., Studerus E., Seifritz E., and Vollenweider F.X. Psilocybine biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors Biol. Psychiatry 72 11 2012 898 906 10.1016/j.biopsych.2012.04.005 22578254
20. Kraehenmann R., Preller K.H., Scheidegger M., Pokorny T., Bosch O.G., Seifritz E., and Vollenweider F.X. Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biol Psychiatry 2014
21. Lang P.J., Bradley M.M., and Cuthbert B.N. International affective picture system (IAPS) Affective Ratings of Pictures and Instruction Manual 2005 NIMH, Center for the Study of Emotion & Attention Gainesville, FL CD-ROM
22. Leuner H. Halluzinogene. Psychische Grenzzustände in Forschung und Psychotherapie 1981 Hans Huber Bern, Stuttgart, Wien
23. Lu Q., Li H., Luo G., Wang Y., Tang H., Han L., and Yao Z. Impaired prefrontal-amygdala effective connectivity is responsible for the dysfunction of emotion process in major depressive disorder: a dynamic causal modeling study on MEG Neurosci. Lett. 523 2 2012 125 130 10.1016/j.neulet.2012.06.058 22750155
24. Morris J.S., Friston K.J., Büchel C., Frith C.D., Young A.W., Calder A.J., and Dolan R.J. A neuromodulatory role for the human amygdala in processing emotional facial expressions Brain 121 1 1998 47 57 10.1093/brain/121.1.47 9549487
25. Outhred T., Hawkshead B.E., Wager T.D., Das P., Malhi G.S., and Kemp A.H. Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: implications for differential treatment efficacy Neurosci. Biobehav. Rev. 37 8 2013 1786 1800 10.1016/j.neubiorev.2013.07.010 23886514
26. Penny W.D., Stephan K.E., Mechelli A., and Friston K.J. Comparing dynamic causal models Neuroimage 22 3 2004 1157 1172 10.1016/j.neuroimage.2004.03.026 15219588
27. Pessoa L., and Adolphs R. Emotion processing and the amygdala: from a 'low road' to 'many roads' of evaluating biological significance Nat. Rev. Neurosci. 11 11 2010 773 783 10.1038/nrn2920 20959860
28. Rainnie D.G. Serotonergic modulation of neurotransmission in the rat basolateral amygdala J. Neurophysiol. 82 1 1999 69 85 10400936
29. Robinson O.J., Overstreet C., Allen P.S., Letkiewicz A., Vytal K., Pine D.S., and Grillon C. The role of serotonin in the neurocircuitry of negative affective bias: serotonergic modulation of the dorsal medial prefrontal-amygdala 'aversive amplification' circuit Neuroimage 78 2013 217 223 10.1016/j.neuroimage.2013.03.075 23583742
30. Schmidt A., Kometer M., Bachmann R., Seifritz E., and Vollenweider F. The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions Psychopharmacology (Berl.) 225 1 2013 227 239 10.1007/s00213-012-2811-0 22836372
31. Schmidt A., Smieskova R., Aston J., Simon A., Allen P., Fusar-Poli P., McGuire P.K., Riecher-Rössler A., Stephan K.E., and Borgwardt S. Brain connectivity abnormalities predating the onset of psychosis: correlation with the effect of medication J.A.M.A. Psychiatry 70 9 2013 903 912 10.1001/jamapsychiatry.2013.117 23824230
32. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., and Hergueta T. baker Dunbar R. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J. Clin. Psychiatry 59 Suppl. 20 1998 22 33
33. Sladky R., Spies M., Hoffmann A., Kranz G., Hummer A., Gryglewski G., Lanzenberger R., Windischberger C., and Kasper S. (S)-citalopram Influences Amygdala Modulation in Healthy Subjects: A Randomized Placebo-controlled Double-blind fMRI Study Using Dynamic Causal Modeling 108 2015 243 250
34. Spielberger C.D., and Gorsuch R.L. Manual for the State-Trait Anxiety Inventory (Form Y) ("Self-Evaluation Questionnaire") iv 1983 Consulting Psychologists Press Palo Alto, CA 36
35. Stephan K.E., Penny W.D., Daunizeau J., Moran R.J., and Friston K.J. Bayesian model selection for group studies Neuroimage 46 4 2009 1004 1017 10.1016/j.neuroimage.2009.03.025 19306932
36. Stephan K.E., Weiskopf N., Drysdale P.M., Robinson P.A., and Friston K.J. Comparing hemodynamic models with DCM Neuroimage 38 3 2007 387 401 10.1016/j.neuroimage.2007.07.040 17884583
37. Studerus E., Kometer M., Hasler F., and Vollenweider F.X. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies J. Psychopharmacol. (Oxford) 25 11 2011 1434 1452 10.1177/0269881110382466 20855349
38. Vollenweider F.X., and Kometer M. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders Nat. Rev. Neurosci. 11 9 2010 642 651 10.1038/nrn2884 20717121
39. Volman I., Verhagen L., den Ouden H.E.M., Fernández G., Rijpkema M., Franke B., Toni I., and Roelofs K. Reduced serotonin transporter availability decreases prefrontal control of the amygdala J. Neurosci. 33 21 2013 8974 8979 10.1523/JNEUROSCI.5518-12.2013 23699508
40. Vuilleumier P. Affective and motivational control of vision Curr. Opin. Neurol. 28 1 2015 29 35 10.1097/WCO.0000000000000159 25490197
41. Watson D., Clark L.A., and Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales J. Pers. Soc. Psychol. 54 6 1988 1063 1070 10.1037/0022-3514.54.6.1063 3397865